Dermakare Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Lucknow, Uttar Pradesh, India, established in 2011.
2011 Lucknow, Uttar Pradesh, India Active
Last Updated:
Access Report
About Dermakare Pharmaceuticals Private Limited

Dermakare Pharmaceuticals Private Limited, a active private limited company, was established on 12 February 2011 in Lucknow, Uttar Pradesh, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U74900UP2011PTC043538. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹6.18 M.

It upholds a compliant status. Employing 48 professional, Its leadership includes Veshali Porwal (Director), Madhuri Mishra (Director), Archana (Director). Past directors included Manu Mishra, Laxmi Kant, Sumit Porwal. It holds ₹4.43 Cr open charges and ₹4.11 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at F-390 Transport Nagar Kanpur Road, Lucknow, Uttar Pradesh, 226012.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74900UP2011PTC043538

  • Registration Number

    043538

  • Incorporation Date

    12 February 2011

  • Authorized Capital

    ₹2.00 Cr

  • Paid-Up Capital

    ₹6.18 M

  • ROC Code

    Roc Kanpur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.00 Cr
  • Paid Up Capital ₹ 6.18 M
  • Company Age 15 Year, 2 Days
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 4.43 Cr
  • Satisfied Charges ₹ 4.11 Cr
  • Revenue Growth **** 17.48%
  • Profit Growth **** 78.54%
  • Ebitda **** 12.94%
  • Net Worth 4.96%
  • Total Assets **** 18.92%
Company report

Dermakare Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Dermakare Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Dermakare Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Veshali Porwal Director 01 May 2013 Current
Madhuri Mishra Director 15 Jul 2013 Current
Archana Director 01 May 2013 Current
Roop Chand Rastogi Director 12 Feb 2011 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 May 2013 Past
Pramod Abcsdd Director 24 May 2011 Past
Pramod Abcsdd Director 15 Jul 2013 Past
Pramod Abcsdd Director 01 May 2013 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Dermakare Pharmaceuticals.

Dermakare Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 17.48% increase. The company also saw a substantial improvement in profitability, with a 78.54% increase in profit. The company's net worth moved up by a moderate rise of 4.96%.

Dermakare Pharmaceuticals revenue growth over time
Dermakare Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 17.48%
*******
*******
*******
*******
Revenue from Operations
*******
 17.48%
*******
*******
*******
*******
Total Assets
*******
 18.92%
*******
*******
*******
*******
Profit or Loss
*******
 78.54%
*******
*******
*******
*******
Net Worth
*******
 4.96%
*******
*******
*******
*******
EBITDA
*******
 12.94%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Dermakare Pharmaceuticals?

In 2023, Dermakare Pharmaceuticals had a public holding of 91.12%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹44,336,810.00

Satisfied Charges

₹41,100,000.00

Charges Breakdown by Lending Institutions
  • Others : 4.08 Cr
  • Axis Bank Limited : 0.35 Cr
Latest Charge Details
Date Lender Amount Status
28 Jan 2022 Others ₹4.08 Cr Open
06 Aug 2021 Axis Bank Limited ₹3.54 M Open
29 Jun 2020 Others ₹5.40 M Satisfied
29 Nov 2014 Others ₹3.50 Cr Satisfied
29 Jan 2014 Canara Bank ₹0.70 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Dermakare Pharmaceuticals?

Dermakare Pharmaceuticals has a workforce of 48 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Dermakare Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dermakare Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Dermakare Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Dermakare Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Dermakare Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was completed.

  • Charges

    A charge with Others of Rs. 4.08 Cr registered on 28 Jan 2022 with Charge ID 100549646 was modified on 10 May 2022. was recorded as a recent event.

  • Charges

    Progress on A charge registered on 29 Jun 2020 via Charge ID 100368401 with Others was fully satisfied on 10 Mar 2022. was documented.

  • Charges

    Progress on A charge registered on 29 Nov 2014 via Charge ID 10535427 with Others was fully satisfied on 10 Mar 2022. was documented.

  • Charges

    The activity A charge with Others amounted to Rs. 4.08 Cr with Charge ID 100549646 was registered on 28 Jan 2022. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Dermakare Pharmaceuticals Private Limited?

The CIN of Dermakare Pharmaceuticals Private Limited is U74900UP2011PTC043538.

Where is Dermakare Pharmaceuticals Private Limited headquartered?

Dermakare Pharmaceuticals Private Limited is headquartered at F-390 Transport Nagar Kanpur Road, Lucknow, Uttar Pradesh, 226012.

When was Dermakare Pharmaceuticals Private Limited incorporated?

Dermakare Pharmaceuticals Private Limited was incorporated on 12 February 2011.

Who are the current directors of Dermakare Pharmaceuticals Private Limited?

The current directors of Dermakare Pharmaceuticals Private Limited are

What is the primary industry of Dermakare Pharmaceuticals Private Limited?

The primary industry of Dermakare Pharmaceuticals Private Limited is Trade.

Is Dermakare Pharmaceuticals Private Limited a listed company?

Dermakare Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Dermakare Pharmaceuticals Private Limited?

The authorized capital of Dermakare Pharmaceuticals Private Limited is ₹2.00 Cr, and the paid-up capital is ₹6.18 M.

What is the compliance status of Dermakare Pharmaceuticals Private Limited?

The compliance status of Dermakare Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available